These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7852772)

  • 1. [Rectosigmoidectomy following neoadjuvant chemotherapy for advanced ovarian cancer].
    Kato T; Shimizu Y; Umezawa S; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Dec; 46(12):1337-42. PubMed ID: 7852772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multimodal treatment for advanced, ovarian cancer patients with poor performance status--its effectiveness and limitations].
    Shimizu Y; Tatsuki Y; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Dec; 44(12):1551-8. PubMed ID: 1484219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Schwartz PE; Chambers JT; Makuch R
    Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of advanced ovarian cancer--is residual tumor diameter less than 2cm optimal?].
    Shimizu Y; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1129-35. PubMed ID: 8245592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical indications for combined partial rectosigmoidectomy in ovarian cancer.
    Takahashi O; Sato N; Miura Y; Ogawa M; Fujimoto T; Tanaka H; Sato H; Tanaka T
    J Obstet Gynaecol Res; 2005 Dec; 31(6):556-61. PubMed ID: 16343259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
    Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics of hereditary ovarian cancer syndrome].
    Zhong Y; Sheng XG; Ma ZF; Ma YB; Liu NF; Chen YT; Gao R; Wang YY; Sun L
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):676-80. PubMed ID: 20079180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion].
    Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.
    Lawton FG; Redman CW; Luesley DM; Chan KK; Blackledge G
    Obstet Gynecol; 1989 Jan; 73(1):61-5. PubMed ID: 2462202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
    Ivanov S; Ivanov S; Khadzhiolov N
    Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.
    Lim MC; Song YJ; Seo SS; Yoo CW; Kang S; Park SY
    Onkologie; 2010; 33(6):324-30. PubMed ID: 20523098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis and prognostic factor analysis epithelial ovarian cancer].
    Wen H; Sun W; Guo Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):159-62. PubMed ID: 9596891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
    Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
    Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.